Add to wishlist

Tumor Imaging: CT Colonography Online Course 2022 (Videos)

$40.00

Format: 8 Videos

Category:

Posted By: Dr_magic

0 Rating

published date: 26 Jan 23

This course is an excerpt from the Tumor Imaging Categorical Course. It only includes the Lung Cancer lectures. A book is NOT included with this purchase. Participants will gain the interpretive, technical, and systems knowledge radiologists need to provide quality lung cancer screening, while learning strategies to address overall care disparities. This course includes discussions of screening, treatments, pitfalls and a look into the future of lung cancer screening.
Target Audience:
The target audience for this activity is radiologists and radiologists in training with an interest in lung cancer screening.
Goals and Objectives:
After completing the material in this article, the learner should be able to:

  1. Discuss the role of imaging and staging and assessment for treatment response in lung cancer patients.
  2. Review lung cancer staging and potential pitfalls on imaging.
  3. Discuss imaging findings during lung cancer therapy.
  4. Explain the structure of current screening programs and the radiologic reporting systems.
  5. Summarize the treatment options for primary and secondary lung neoplasms.

Module 1: Lung Cancer Screening, Missed Cases and Staging

  • Efren Flores has nothing to disclose.
  • Suzanne Byrne has nothing to disclose.
  • Lucy Modahl has nothing to disclose.
  • Dexter Mendoza has nothing to disclose.
  • Alejandra Cardona has nothing to disclose.
  • Mark H. Hammer has nothing to disclose.
  • Francine L. Jacobson has nothing to disclose.
  • Jo-Anne O. Shepard has nothing to disclose.
  • John M. Archer has nothing to disclose.

Module 2: Lung Cancer Imaging Interventions and Advancements

  • Florian Fintelmann has nothing to disclose.
  • Saurabh Agarwal has nothing to disclose.
  • Subba Digumarthy receives honorarium as an Instructor at a workshop for siemens Medical Solutions.
  • Rydhwana Hossain has nothing to disclose.
  • Mark C. Murphey has nothing to disclose.
  • Maria M. Wrobel has nothing to disclose.
  • Alexis M. Cahalane has nothing to disclose.
  • John M. Archer has nothing to disclose.
  • Amanda Marrero has nothing to disclose.
  • Allison Herring has nothing to disclose.
  • Charles White is on Riverain Medical's Advisory Board and the recipient of financial compensation.